人造肝脏研究进展

王鑫英; 周伦; 陈亚慧

doi:10.3969/j.issn.1674-7445.2017.06.014

人造肝脏研究进展

doi: 10.3969/j.issn.1674-7445.2017.06.014

100083 北京奇点万象科技有限公司

详细信息

通讯作者:
王鑫英, Email: wangxinying707@163.com

中图分类号: R617, R318
计量
- 文章访问数: 331
- HTML全文浏览量: 86
- PDF下载量: 6
- 被引次数: 0
出版历程
- 收稿日期: 2017-08-21
- 网络出版日期: 2021-01-19
- 刊出日期: 2017-11-15

摘要

摘要: 肝移植是目前公认的治疗终末期肝病的最有效措施，但肝供体短缺成为全球移植界面临的难题。如何解决这一问题成为各国科学家研究的重点。本文从人造肝脏的培育历史出发，总结了近年来人造肝脏的研究进展，以期为人造肝脏的研究提供参考。
- 肝移植 /
- 人造肝脏 /
- 3D打印 /
- 肝脏再生 /
- 异位移植 /
- 人造肝脏种子

HTML全文

图 1 世界上首个人造肝脏及其发明者Forraz博士^[7]

Figure 1. World's first artificial liver and it's creator Dr Forraz

下载: 全尺寸图片幻灯片

图 2 3D打印的碳水化合物玻璃晶格^[10]

Figure 2. 3D printed carbohydrate glass lattice

下载: 全尺寸图片幻灯片

图 3 2011年Bhatia教授团队构建的人造肝脏示意图^[12]

Figure 3. Schematic diagram of artificial liver created by Professor Bhatia teams in 2011

下载: 全尺寸图片幻灯片

图 4 Bhatia团队构建的人造肝脏“种子”流程图^[16]

Figure 4. Flow chart of construction of artificial liver seed grafs created by Bhatia teams

下载: 全尺寸图片幻灯片

参考文献(18)

[1]	Starzl TE, Koep LJ, Halgrimson CG, et al. Fifteen years of clinical liver transplantation[J]. Gastroenterology, 1979, 77(2): 375-388.
[2]	中国肝移植年度科学报告[EB/OL]. [2017-07-08]. http://www.cltr.org/pages/index.jsp.
[3]	陈规划.中国大陆肝移植:过去、现在和将来[J].器官移植, 2010, 1(1): 5-6. DOI: 10.3969/j.issn.1674-7445.2010.01.001. Chen GH. The past, present and future of liver transplantation in mainland China[J]. Organ Transplant, 2010, 1(1): 5-6. DOI: 10.3969/j.issn.1674-7445.2010.01.001.
[4]	中华医学会器官移植学分会, 中国医师协会器官移植医师分会.中国儿童肝移植临床诊疗指南(2015版)[J].临床肝胆病杂志, 2016, 32(7): 1235-1244. DOI: 10.3969/j.issn.1001-5256.2016.07.001. Branch of Organ Transplantation of Chinese Medical Association, Branch of Organ Transplant Physician of Chinese Medical Doctor Association. Clinical guidelines for pediatric liver transplantation in China (2015)[J]. J Clin Hepatol, 2016, 32(7): 1235-1244. DOI: 10.3969/j.issn.1001-5256.2016.07.001.
[5]	周霞, 韩英. 干细胞在肝脏疾病治疗中的临床应用及分子机制[J/CD]. 中华细胞与干细胞杂志(电子版), 2015, 5(2): 58-65. DOI: 10.3877/cma.j.issn.2095-1221.2015.02.012. Zhou X, Han Y. Clinical application and molecular mechanisms of stem cell therapy for liver disease[J/CD]. Chin J Cell Stem Cell(Electr Edit), 2015, 5(2): 58-65. DOI: 10.3877/cma.j.issn.2095-1221.2015.02.012.
[6]	Christensen B. World's first artificial human liver grown in lab[EB/OL]. (2006-10-31)[2017-07-08]. https://www.livescience.com/4276-world-artificial-human-liver-grown-lab.html.
[7]	British scientists grow human liver in a laboratory[EB/OL]. [2017-07-08]. https://lifeboat.com/ex/bios.nico.forraz.
[8]	Huang H, Oizumi S, Kojima N, et al. Avidin-biotin binding-based cell seeding and perfusion culture of liver-derived cells in a porous scaffold with a three-dimensional interconnected flow-channel network[J]. Biomaterials, 2007, 28(26): 3815-3823. DOI: 10.1016/j.biomaterials.2007.05.004.
[9]	Huang Y, He K, Wang X. Rapid prototyping of a hybrid hierarchical polyurethane-cell/hydrogel construct for regenerative medicine[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(6): 3220-3229. DOI: 10.1016/j.msec.2013.03.048.
[10]	Miller JS, Stevens KR, Yang MT, et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues[J]. Nat Mater, 2012, 11(9): 768-774. DOI: 10.1038/nmat3357.
[11]	Kizawa H, Nagao E, Shimamura M, et al. Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery[J]. Biochem Biophys Rep, 2017(10): 186-191. http://www.sciencedirect.com/science/article/pii/S2405580817300596
[12]	Chen AA, Thomas DK, Ong LL, et al. Humanized mice with ectopic artificial liver tissues[J]. Proc Natl Acad Sci U S A, 2011, 108(29): 11842-11847. DOI: 10.1073/pnas.1101791108.
[13]	Trafton A. Engineered liver tissue expands after transplant tiny implantable " seeds" of tissue produce fully functional livers.[EB/OL]. [2017-07-08]. http://news.mit.edu/2017/engineered-liver-tissue-expands-after-transplant-0719.
[14]	Greene AK, Wiener S, Puder M, et al. Endothelial-directed hepatic regeneration after partial hepatectomy[J]. Ann Surg, 2003, 237(4): 530-535. DOI: 10.1097/01.SLA.0000059986.96051.EA.
[15]	Baranski JD, Chaturvedi RR, Stevens KR, et al. Geometric control of vascular networks to enhance engineered tissue integration and function[J]. Proc Natl Acad Sci U S A, 2013, 110(19): 7586-7591. DOI: 10.1073/pnas.1217796110.
[16]	Stevens KR, Ungrin MD, Schwartz RE, et al. InVERT molding for scalable control of tissue microarchitecture[J]. Nat Commun, 2013, 4:1847. DOI: 10.1038/ncomms2853.
[17]	de Jong YP, Dorner M, Mommersteeg MC, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection[J]. Sci Transl Med, 2014, 6(254): 254ra129. DOI: 10.1126/scitranslmed.3009512.
[18]	Stevens KR, Scull MA, Ramanan V, et al. In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease[J]. Sci Transl Med, 2017, 9(399). DOI: 10.1126/scitranslmed.aah5505.